| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1996 | 2019 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2017 | |||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2002 | 2014 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2019 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2014 | ||||||||
|
fibroblast growth factor 7 | 0.519 | 0.846 | 0.77 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2017 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1995 | 2014 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1993 | 2017 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2010 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2014 | ||||||||
|
tissue factor pathway inhibitor | 0.486 | 0.808 | 0.25 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
defensin beta 4A | 0.507 | 0.769 | 1.2E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2007 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2020 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2007 | ||||||||
|
bone morphogenetic protein 2 | 0.432 | 0.846 | 0.99 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2014 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2015 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 | ||||||||
|
C-type lectin domain family 4 member D | 0.587 | 0.538 | 2.5E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
keratin 16 | 0.565 | 0.769 | 1.5E-14 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1993 | 1994 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2004 | ||||||||
|
ataxin 3 | 0.521 | 0.808 | 0.11 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
defensin beta 1 | 0.509 | 0.808 | 0.41 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2006 | ||||||||
|
cathelicidin antimicrobial peptide | 0.466 | 0.846 | 4.4E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2014 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2006 | ||||||||
|
defensin beta 4B | 0.510 | 0.769 | 6.8E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2007 |